1. Home
  2. CCCC vs MBOT Comparison

CCCC vs MBOT Comparison

Compare CCCC & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • MBOT
  • Stock Information
  • Founded
  • CCCC 2015
  • MBOT 2010
  • Country
  • CCCC United States
  • MBOT United States
  • Employees
  • CCCC N/A
  • MBOT N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • MBOT Medical/Dental Instruments
  • Sector
  • CCCC Health Care
  • MBOT Health Care
  • Exchange
  • CCCC Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • CCCC 104.4M
  • MBOT 99.3M
  • IPO Year
  • CCCC 2020
  • MBOT N/A
  • Fundamental
  • Price
  • CCCC $1.54
  • MBOT $2.46
  • Analyst Decision
  • CCCC Buy
  • MBOT Strong Buy
  • Analyst Count
  • CCCC 3
  • MBOT 1
  • Target Price
  • CCCC $12.00
  • MBOT $9.00
  • AVG Volume (30 Days)
  • CCCC 995.5K
  • MBOT 1.7M
  • Earning Date
  • CCCC 07-31-2025
  • MBOT 08-13-2025
  • Dividend Yield
  • CCCC N/A
  • MBOT N/A
  • EPS Growth
  • CCCC N/A
  • MBOT N/A
  • EPS
  • CCCC N/A
  • MBOT N/A
  • Revenue
  • CCCC $39,783,000.00
  • MBOT N/A
  • Revenue This Year
  • CCCC N/A
  • MBOT N/A
  • Revenue Next Year
  • CCCC N/A
  • MBOT N/A
  • P/E Ratio
  • CCCC N/A
  • MBOT N/A
  • Revenue Growth
  • CCCC 98.56
  • MBOT N/A
  • 52 Week Low
  • CCCC $1.09
  • MBOT $0.82
  • 52 Week High
  • CCCC $7.66
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 50.55
  • MBOT 49.38
  • Support Level
  • CCCC $1.36
  • MBOT $2.30
  • Resistance Level
  • CCCC $1.63
  • MBOT $2.52
  • Average True Range (ATR)
  • CCCC 0.14
  • MBOT 0.14
  • MACD
  • CCCC -0.00
  • MBOT -0.02
  • Stochastic Oscillator
  • CCCC 38.33
  • MBOT 40.91

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: